New daily shot could tame severe MG attacks
Disease control
Recruiting now
This study tests a daily injection called zilucoplan in 15 people hospitalized with severe myasthenia gravis (MG) flare-ups. The goal is to see if the drug can quickly improve daily living activities, like breathing and swallowing, within two weeks. Participants receive the injec…
Phase: PHASE3 • Sponsor: Miriam Freimer • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC